News
Hosted on MSN1mon
FDA proposes removal of common decongestant“Phenylephrine is an oral decongestant and vasoconstrictor ... that it will hopefully clear up some sinus issues.” The FDA has proposed to remove oral phenylephrine, saying citing evidence ...
(The Hill) — The Food and Drug Administration (FDA) is proposing the removal from the market of ... phenylephrine is not effective as a nasal decongestant when taken in liquid or pill form ...
The FDA's Delaney Clause mandates the removal of any substance from human foods if it is found to cause cancer in animals. While Red Dye No. 3 was banned in cosmetics in the 1990s, its continued ...
US Judge Sides With FDA's Removal of Lilly's Weight Loss Drug From Shortage List By Patrick Wingrove (Reuters) -A U.S. federal judge has sided with a U.S. regulator's decision last year to take ...
But once the FDA determined the drugs were no longer in short supply, the compounders could no longer satisfy patient demand, which swelled exponentially and created the equivalent of a gold rush ...
A federal judge has upheld the FDA’s decision to remove Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro from the national drug shortage list, Reuters reported May 7.
He spent much of the conversation with Kelly lambasting his agency for its ties to industry, and said he was shocked to learn that drug industry representatives are allowed to sit on FDA advisory ...
May 7 (Reuters) - A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s (LLY.N), opens new tab blockbuster weight loss and diabetes drugs Zepbound and ...
U.S. District Judge Mark Pittman in Texas issued the order on Wednesday under seal in response to an October lawsuit from a compounding industry group against the FDA's edict. The judge in March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results